The invention relates in general to medical device programming and, specifically, to a system and method for remotely programming a patient medical device.
The Food & Drug Administration (FDA) categorizes medical devices into three classes based on medical regulations and federal law. Class III medical devices are subject to continuing regulatory control and can only be interrogated and programmed under the supervision of licensed medical caregivers. Class III medical devices include implantable medical devices (IMDs), such as cardiac pacemakers, defibrillators, and cerebella stimulators, and certain types of external medical devices (EMDs), such as automatic external defibrillators (AEDs).
Historically, the interrogation and programming of Class III medical devices had to be performed in a clinic or hospital using FDA-regulated programmer recorders, which use inductive or, more recently, wireless telemetry, such as radio frequency (RF) telemetry, to retrieve patient data and device settings and to apply new programming. Clinic visits, though, incur time, expense, and inconvenience, even when modest. Thus, to improve patient care, patient-operable monitors, such as repeaters, were developed to enable caregivers to remotely access their patients' medical devices outside of a clinic or hospital. These monitors can remotely retrieve patient data and device settings, which are periodically delivered to a repository for caregiver consideration and archival.
Despite their convenience, patient-operable monitors are not presently permitted to program medical devices for reasons of patient safety and regulatory compliance. For instance, programming cannot be performed by a non-FDA-regulated device, so any remote programming must currently include interfacing through a device that is properly regulated. As well, some device parameters are used to test device operation in situ and can be potentially life-threatening. Consequently, these parameters must only be modified in-clinic with life safety equipment and trained medical personnel in attendance. Finally, patient consent is implied when programming is performed in-clinic, but must be explicitly secured before remote programming is attempted. Conventional approaches fail to adequately address these issues.
For instance, U.S. Pat. No. 7,060,031 issued Jun. 13, 2006 to Webb et al., discloses a system and method for remotely programming IMDs. Pending programming requests are placed in a request queue that is ordered from older to most recent request. The requests can be encrypted and assigned sequence numbers that enable a remote monitor to determine that the request is later in sequence than any earlier requests previously applied to the IMD. Webb, however, assumes fully regulated infrastructure to effect remote programming. Moreover, such an infrastructure is costly to deploy and may not be available when a physician is called upon to make programming changes.
Therefore, there is a need for an approach to performing remote medical device programming that assures both patient safety and compliance without requiring a regulated environment as the only means to specify programming.
A system and method for enabling caregivers to perform programming of patient medical devices (PMDs), either IMDs or EMDs, remotely includes a pair of control zones to logically separate regulated and non-regulated components. Caregivers can specify programming instructions using non-regulated components, such as a dedicated application executing on a personal computer or a Web client, or regulated components, such as a remotely-connectable programmer. The programming instructions can be specified in real time or deferred time. The caregivers are only able to select those programming instructions that specify operations which can be performed safely when the patient is not in the presence of a caregiver, to avoid endangering the patient. Programming instructions that originate in the non-regulated control zone are forwarded through the servers into the regulated control zone. Each programming instruction is translated into commands formatted in PMD representation, which are checked for correctness. The PMD-formatted commands are digitally signed by a trusted server. The PMD-formatted commands are converted into a simple Web page or displayable representation, which is sent back to the caregiver to review for accuracy. Upon caregiver approval, the PMD-formatted commands are marked for delivery to the remote programming device (RPD). The PMD-formatted commands are verified by the RPD, the IMD, or both devices, for authenticity and integrity. If successfully verified, the PMD-formatted commands are applied to the PMD. The PMD is then interrogated to retrieve post-programming data for confirmation and caregiver review.
One embodiment provides a system and method for remotely programming a patient medical device (PMD). Programming instructions specified remotely are translated into commands formatted for a PMD to control functionality thereof. Correctness of the PMD-formatted commands is checked. Patient consent to modify the functionality of the PMD is confirmed. Application of the PMD-formatted commands to the PMD is controlled during a programming session initiated and performed remotely. The application of the PMD-formatted commands is confirmed through interrogation of the PMD to verify the functionality modified.
Still other embodiments will become readily apparent to those skilled in the art from the following detailed description, wherein are described embodiments of the invention by way of illustrating the best mode contemplated for carrying out the invention. As will be realized, the invention is capable of other and different embodiments and its several details are capable of modifications in various obvious respects, all without departing from the spirit and the scope of the present invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.
Although described here in relation to IMDs and EMDs intended for providing cardiac and cardiopulmonary therapy and monitoring, the embodiments described apply generally to all forms of patient medical devices capable of being remotely interrogated and programmed.
Remote Programming System
Fundamentally, the remote programming of PMDs requires logically separating components that must be kept in compliance with FDA and other applicable patient care regulations and guidelines from other components. Remote programming also requires establishing and managing reliable, safe, and trustworthy cooperation among all of these components.
The regulated control zone 31 includes four loosely grouped sets of components. First, caregivers are able to specify programming instructions for a PMD using either a data entry mechanism in the non-regulated control zone 32 or through a regulated but remotely-connectable data entry mechanism in the regulated control zone 31, such as a remotely-connectable programmer 19. Other regulated data entry mechanisms are possible. All PMDs are also grouped into the regulated control zone 31 and include IMDs 12, such as pacemakers, implantable cardiac defibrillators (ICDs), drug pumps, and neuro-stimulators; EMDs 14, such as automatic external defibrillators (AEDs); implantable sensors 13, such as heart and respiratory monitors and diagnostic multi-sensor non-therapeutic devices; and external sensors 15, such as Holter monitors. Other types of implantable or external PMDs for therapeutic, diagnostic, or other medical purpose are possible. Each patient 11 having a PMD 12-15 that is suitable for remote programming has an RPD 17, such as a repeater or patient communicator, which is a form of regulated device that enables caregivers to remotely access their patients' PMDs outside of a clinic or hospital. Finally, each RPD 17 receives digitally signed PMD-formatted commands from a regulated server 24, which is trusted in the sense of data security and is capable of supporting regulated component execution, including regulated software applications 30, or directly from a regulated data entry mechanism, such as a remotely-connectable programmer 19. The regulated server 24 communicates with the RPD 17 over a trusted network 28 and with components in the non-regulated zone 32 via a dedicated secure connection 33 to a non-regulated server 22. Other regulated system components are possible.
The non-regulated control zone 32 includes all other components, including non-regulated data entry mechanisms, servers, and PMDs. For instance, caregivers are able to specify programming instructions using a remote Web client 18, a dedicated application 20 executing on a personal computer 34, or local Web client 21. Programming instructions that originate from any of these non-regulated data entry mechanisms, as well as from remotely-connectable regulated data entry mechanisms, must be forwarded to the regulated server 24 through a non-regulated server 22 that is connected via an open network 27. Finally, PMDs that are not regulated, such as a weight scale 16 or blood pressure cuff (not shown), do not generally affect patient safety and can be grouped as part of the non-regulated control zone 32. Other non-regulated system components are possible.
The regulated server 24 and non-regulated servers 22 serve as a gateway between the regulated and non-regulated control zones 31, 32, and exchange messages over a dedicated secure connection 33. The regulated server 24 is able to run regulated applications 30, whereas the non-regulated server 22 does not. However, the non-regulated server 22 can execute a wider range of non-regulated applications 29, such as a Web server (not shown) for providing Web content to the Web clients 18, 21. The functionality of the regulated and non-regulated servers 22, 24 can be hosted physically on the same hardware platform, but the execution of and any modifications to the regulated applications 30 must remain controlled for compliance. The regulated and non-regulated servers 22, 24 also share access to secure storage 26, in which patient data and other information can be safely stored. Other server and storage functionality are possible.
Network-capable components in the regulated control zone 31 rely on a trusted network 28, while network-capable components in the non-regulated control zone 32 communicate via an open network 27 or, in a further embodiment, via the trusted network 28. The trusted network 28 is a private wide area network and can include both conventional wired and wireless secure interconnectivity. The open network 27 is a non-private wide area network, such as the Internet, that can similarly include both conventional wired and wireless interconnectivity. In a further embodiment, the trusted network 28 can operate over a public wide area network; however, communications must be encrypted or otherwise protected to ensure patient privacy and to guard against compromise or interference, such as through the use of a Virtual Private Network. Both the trusted network 28 and the open network 27 are based on the Transmission Control Protocol/Internet Protocol (TCP/IP) network communication protocols, although other communication protocols are possible. Other trusted and open network topologies and configurations are possible.
The RPD 17 can interrogate and program the PMDs 12-16, either through direct means, such as wired connectivity, or through indirect means, such as inductive coupled telemetry, optical telemetry, or selective radio frequency or wireless telemetry based on, for example, “strong” Bluetooth or IEEE 802.11 wireless fidelity “WiFi” and “WiMax” interfacing standards. Other forms of medical device interfacing are possible. In a further embodiment, the PMDs 12-16 are also remotely managed through the RPD 17, for example, such as described in commonly-assigned U.S. Patent application, entitled, “System and Method for Managing Alert Notifications in an Automated Patient Management System,” Ser, No. 11/121,870, filed May 3, 2005, pending, the disclosure of which is incorporated by reference.
In a further embodiment, subjective impressions of personal wellness, which constitute qualitative data values, can be collected for post-programming considerations. For example, answers to health questions pertaining to patient well-being can be solicited from the patient 11 and collected following a change in PMD programming. To provide subjective impressions, the patient 11 would enter their data into a device that incorporates a user interface, such as a personal computer or telephone handset (not shown), or the RPD 17, if so equipped.
In a further embodiment, collected patient data can be evaluated by an RPD 17 or server 22, 24 for the occurrence of one or more chronic or acute health conditions, such as described in related, commonly-owned U.S. Pat. No. 6,336,903, to Bardy, issued Jan. 8, 2002; U.S. Pat. No. 6,368,284, to Bardy, issued Apr. 9, 2002; U.S. Pat. No. 6,398,728, to Bardy, issued Jun. 2, 2002; U.S. Pat. No. 6,411,840, to Bardy, issued Jun. 25, 2002; and U.S. Pat. No. 6,440,066, to Bardy, issued Aug. 27, 2002, the disclosures of which are incorporated by reference.
In a still further embodiment, patient data is safeguarded against unauthorized disclosure to third parties, including during collection, assembly, evaluation, transmission, and storage, to protect patient privacy and comply with recently enacted medical information privacy laws, such as the Health Insurance Portability and Accountability Act (HIPAA) and the European Privacy Directive. At a minimum, patient health information that identifies a particular individual with health- and medical-related information is treated as protectable, although other types of sensitive information in addition to or in lieu of specific patient health information could also be protectable.
Structurally, the servers 22, 24 are server-grade computing platforms configured as a uni-, multi- or distributed processing systems, and the Web clients 18, 21 execute Web browser or equivalent applications on a general-purpose computing platform, such as a personal desktop or notebook computer, or other Web-enabled device. The servers 22, 24, Web clients 18, 21, and personal computer 34 that executes a dedicated application 20 include those components conventionally found in computing devices, such as, for example, a central processing unit (CPU), memory, network interface, persistent storage, and various components for interconnecting these components.
Data Flows
Generally, data is exchanged between the components of the regulated and non-regulated control zones in four phases. Briefly, during the first phase, a caregiver specifies remote programming instructions and accompanying parameters, using a data entry mechanism, that are subsequently translated into PMD-formatted commands to be validated by the caregiver, that is, either accepted or rejected, during the next phase. Upon acceptance, the PMD-formatted commands are provided to an RPD. The PMD-formatted commands are then verified and applied. The verification can be performed by the RPD, the PMD, or both devices. During the final phase, the PMD is interrogated to obtain physiometry following the remote programming. The phases are discussed in overview with reference to
To maintain control over compliance, data is passed between the control zones only via messages securely exchanged between the regulated and non-regulated servers.
As an overview, caregivers can remotely interrogate and program a PMD 55 using a data entry mechanism 62, which can be located in the non-regulated control zone 52 or, if performed on a regulated device (not shown), in the regulated control zone 51. Where the data entry mechanism 62 is a Web client, Web content 66 is provided to enable the data entry mechanism 62 to present the information formatted as a Web page.
Within the non-regulated control zone 52, the non-regulated server 61 provides PMD settings and patient physiology to the caregiver as pre-programming data 67. The caregiver can then specify programming instructions 63 and any accompanying parameters 64, which are forwarded to the regulated server 53 for translation into commands 56 formatted in PMD representation. The PMD-formatted commands 56 are provided back to the caregiver in displayable form as validation data 68, which the caregiver will accept or reject 65. The caregiver can also review post-remote programming IMD settings and patient data, which are provided by the non-regulated server 61 as post-programming data 69.
Within the regulated control zone 51, caregiver-specified programming instructions 63 and any accompanying parameters 64 are processed by the regulated server 53. The programming instructions 63 and parameters 64 are checked for correctness, as further described below with reference to
Validation data 68 is created within the regulated control zone 51, and delivered to the non-regulated control zone 52 over the dedicated secure connection 33 for presentation to the caregiver.
Following caregiver approval, PMD-formatted commands 56 are delivered to and verified by the RPD 54, the PMD 55, or both devices. Verification includes checking the PMD-formatted commands 56 for authenticity and integrity. Only verified commands are applied to modify the programming of a PMD 55.
Finally, to effect remote programming, the RPD 54 applies the PMD-formatted commands 56 to the PMD 55, as well as any other data 57, such as interrogation commands or firmware patches. Following successful application, the RPD 54 can interrogate the PMD 55 to retrieve patient physiometry 58, parametric data 59, and, if applicable, environmental data 60, which are provided to the data entry mechanism 62 as the post-programming data 69 for confirmation of programming and caregiver review. In a further embodiment, the PMD 55 applies the PMD-formatted commands 56 itself, and can also autonomously provide the patient physiometry 58, parametric data 59, and, if applicable, environmental data 60.
Data Entry
Caregivers can remotely interrogate or program a PMD by specifying programming instructions and any accompanying parameters using a data entry mechanism.
For purposes of remote programming, caregivers are limited to a subset of programmable functions for a PMD that exclude those functions that can only be performed with the patient and caregiver in near physical proximity. The remaining set of “safe” functions is remotely programmable without worry of endangering the patient's safety. Additionally, programming instructions and associated parameters must be converted into commands formatted in PMD representation by a regulated server, or other regulated device capable of PMD-formatted command translation.
The remote programming can be applied to the PMD in either real time or deferred time. Real time remote programming involves an active connection between the data entry mechanism, the PMD, and each component situated in-between. From the perspective of the caregiver, the end-to-end remote programming operations underlying the specification of the programming instructions and parameters all the way through post-programming data review occur as a single session. Thus, a real time remote programming session is most similar to an in-clinic programming session, except for the distances possibly separating the caregiver from the patient and the slight additional latency time needed for command translations, correctness checking, data security, acceptance, and transmission. Deferred time remote programming, on the other hand, involves an intentional delay, that is, remote programming scheduled to be applied at a later time or time interval, or any delay that is longer that the minimal delay necessary to effect end-to-end real time remote programming.
Initially, current patient PMD settings and patient physiology are presented to the caregiver as pre-programming data 81. The pre-programming data 81 is incorporated into a caregiver data entry page 82, which may be a Web page or other representation for display to the caregiver on a data entry mechanism. The caregiver can specify remote programming instructions and any accompanying parameters 83.
To ensure patient safety, only safe remotely programmable functions are displayed through the data entry mechanism for caregiver selection. In a further embodiment, the safe programmable functions can further be limited to:
Upon receipt, the regulated server translates the programming instructions and parameters 83 into PMD-formatted commands 84, which are checked for correctness, as further described below with reference to
Validation
Programming instructions and associated parameters specified using a non-regulated data entry mechanism must be validated by caregivers to confirm correct translation into PMD representation.
Other dispositions of the PMD-formatted commands pending caregiver approval are possible. For instance, the PMD-formatted commands 84 could be stored in the secure storage without first being digitally signed. The commands 84 would only be signed following caregiver approval and unsigned commands would not be sent. Alternatively, the PMD-formatted commands 84 could be digitally signed and stored in the secure storage, but would receive a second digital signature upon receiving caregiver approval. Commands not signed with the second digital signature would not be sent. Finally, the PMD-formatted commands 84 could be signed and stored in the secure storage. Upon receiving caregiver approval, the regulated server would check the digital signature and, if valid, would replace the original digital signature with a new digital signature. Commands not digitally signed for the second time would not be sent. Still other command dispositions are possible.
Verification and Application
The verification and application of the remote programming are performed independent of the devices used to enter, correctness check, and accept the programming.
Upon receiving the accepted PMD-formatted commands 95, the RPD verifies 101 the digital signature, which verifies the authenticity, that is, source, of the commands, as well as the integrity of the commands, as further described below with reference to
In contrast to a clinic or hospital setting in which patient consent can be implied by the near physical proximity of the caregiver and patient, remote programming requires some explicit form of patient consent 102. Patient consent 102 can be confirmed through several approaches, including:
The regulated server can confirm the prior patient consent before sending the accepted PMD formatted commands 95 to the RPD. In a further embodiment, the prior patient consent can be included within the accepted PMD-formatted commands 95, where the prior patient consent can be used by the RPD prior to initiating a remote programming session with the PMD.
Other forms of confirming patient consent 102 are possible.
Once patient consent has been confirmed, the RPD undertakes actual programming 103 by applying the accepted PMD-formatted commands 95 to the PMD during a programming session. The accepted PMD-formatted commands 95 can be applied through short range telemetry, such as inductive telemetry using a wand physically connected to the RPD, or through long range telemetry, such as RF telemetry, which only requires near physical patient proximity to the RPD. In a further embodiment, authentication through induction or other form of short range telemetry, or physical communications or interface, may be necessary prior to commencing a programming session through long range telemetry, such as described in commonly-assigned U.S. patent application Ser. No. 10/800,806, filed Mar. 15, 2004, pending, and U.S. patent application Ser. No. 10/801,150, filed Mar. 15, 2004, pending, the disclosures of which are incorporated by reference.
The programming is transacted in a single session. If the programming session is interrupted, such as by the patient moving out of range or dropping the wand, the patient may be prompted to resume the session. If required, upon obtaining a response from the patient to resume the session, the RPD will retry applying the programming by automatically resuming the session if the interruption has only been for a short duration. If prior patient consent has already been obtained, the RPD can automatically retry without having to first prompt the patient. However, if the patient either ignores the prompt or the interruption continues for a long duration, the programming session is halted and earlier PMD programmed state is restored.
Confirmation
Programming can be confirmed and effectiveness can be evaluated by interrogating the PMD following a remote programming session.
Remote Programming Method
Remote programming is initiated by caregiver action and ends with the reporting of the success or failure of the application of the programming to the intended PMD back to the caregiver.
Initially, a caregiver performs a remote programming session (operation 131) through a data entry mechanism. Caregiver-selected programming instructions and parameters are translated by a regulated server into PMD-formatted commands, which are checked for correctness and digitally signed (operation 132). The PMD-formatted commands are also reverse translated and provided to the caregiver in displayable form for acceptance or rejection (operation 133). If the translated programming is rejected by the caregiver, control reverts back to the caregiver programming session (operation 131). Otherwise, the PMD-formatted commands are marked for delivery to the RPD and, following receipt by the RPD, are verified for authenticity and integrity (operation 134). In a further embodiment, the PMD itself also performs verification of the commands, either in addition to or in lieu of the RPD. Assuming the commands are verified, the patient consent is confirmed (operation 135) prior to application of the commands. However, if the patient does not provide consent, control again reverts back to the programming session (operation 131). Upon consent, the RPD performs a programming session (operation 136). If the session is interrupted and not resumed, or abnormally terminates, the original PMD programming is restored and control reverts back to the programming session (operation 131). Upon successful programming, the RPD interrogates the PMD following programming session completion to report post-programming results to the caregiver (operation 137) for review and evaluation.
Correctness Checking
Caregiver-specified programming instructions and any accompanying parameters must be checked for correctness prior to being applied to a PMD in a remote programming session, both to determine that only permitted settings have been specified and to ensure medical-regulatory compliance.
Verification
Remote programming requires transfer of PMD-formatted commands over a network or other interconnection, which creates a possibility of compromise or corruption. The PMD-formatted commands are safeguarded using digital signing at the source, which is a regulated server for programming originating from a non-regulated data entry mechanism, or a regulated data entry mechanism, such as a programmer.
Staleness and Redundancy Checking
Remote programming introduces a delay between the time that new PMD programming is specified and the time that the resulting PMD-formatted commands are actually applied to the PMD. Delay can cause the programming to become stale or redundant in light of intervening events, such as PMD programming in a clinic or hospital setting.
The accepted PMD-formatted commands 95 can also be checked for redundancy prior to application (operation 172). A timestamp that indicates when the PMD was last programmed can be saved by the PMD. This “last programming” timestamp can be provided as part of the pre-programming data 67 (shown in
While the invention has been particularly shown and described as referenced to the embodiments thereof, those skilled in the art will understand that the foregoing and other changes in form and detail may be made therein without departing from the spirit and scope of the invention.
This non-provisional patent application claims priority under 35 USC §119(e) to U.S. provisional patent application, Ser. No. 60/757,399, filed Jan. 9, 2006 and U.S. provisional patent application, Ser. No. 60/761,462, filed Jan. 24, 2006, the disclosures of which are incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
6024699 | Surwit et al. | Feb 2000 | A |
6083248 | Thompson | Jul 2000 | A |
6168563 | Brown | Jan 2001 | B1 |
6171256 | Joo et al. | Jan 2001 | B1 |
6308099 | Fox et al. | Oct 2001 | B1 |
6336903 | Bardy | Jan 2002 | B1 |
6368284 | Bardy | Apr 2002 | B1 |
6398728 | Bardy | Jun 2002 | B1 |
6411840 | Bardy | Jun 2002 | B1 |
6416471 | Kumar et al. | Jul 2002 | B1 |
6440066 | Bardy | Aug 2002 | B1 |
6497655 | Linberg et al. | Dec 2002 | B1 |
6512954 | Fox et al. | Jan 2003 | B2 |
6792311 | Fox et al. | Sep 2004 | B2 |
6827670 | Stark et al. | Dec 2004 | B1 |
6880085 | Balczewski et al. | Apr 2005 | B1 |
7027872 | Thompson | Apr 2006 | B2 |
7060031 | Webb et al. | Jun 2006 | B2 |
7493165 | Fox et al. | Feb 2009 | B2 |
20050283198 | Haubrich et al. | Dec 2005 | A1 |
20060253301 | Simms et al. | Nov 2006 | A1 |
Number | Date | Country |
---|---|---|
1478432 | Jul 2009 | EP |
WO-0029064 | May 2000 | WO |
WO-02074386 | Sep 2002 | WO |
WO-2004070994 | Aug 2004 | WO |
WO-2005056087 | Jun 2005 | WO |
WO-2005057879 | Jun 2005 | WO |
WO-2007081829 | Jul 2007 | WO |
Entry |
---|
Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-191, 110 Stat. 1936 (Aug. 21, 1996). |
E. Hammond, “National Committee on Vital and Health Statistics, Subcommittee on Health Data Needs, Standards and Security,” http://www.ncvhs.hhs.gov/970211t3.htm, pp. 1-4 (Feb. 11, 1997). |
Security and Electronics Signature Standards; Proposed Rule, Federal Register, vol. 63, No. 155 (Aug. 12, 1998). |
W. Diffie, “The First Ten Years of Public-Key Cryptography,” Proceedings of the IEEE, vol. 76, No. 5, pp. 560-577 (May 1988). |
European Examination Report, “Communication pursuant to Article 94(3) EPC”, European Patent Office, mailed Dec. 5, 2008, for EP Application No. 07715390.5, corresponding to U.S. Appl. No. 11/651,118 (6 pages). |
PCT International Preliminary Report and Written Opinion from International Application No. PCT/US2007/000325, corresponding to U.S. Appl. No. 11/651,118, mailed Jul. 24, 2008 (8 pages). |
Notice of Reasons for Rejection, dated Nov. 29, 2011, for co-pending Japanese Application No. 2008-549579, entitled Remotely Programming a Patient Medical Device (6 pages). |
Number | Date | Country | |
---|---|---|---|
20070185547 A1 | Aug 2007 | US |
Number | Date | Country | |
---|---|---|---|
60757399 | Jan 2006 | US | |
60761462 | Jan 2006 | US |